Literature DB >> 11019968

Phenotype-genotype correlation in CD36 deficiency types I and II.

H Yanai1, H Chiba, H Fujiwara, M Morimoto, K Abe, S Yoshida, Y Takahashi, H Fuda, S P Hui, H Akita, K Kobayashi, K Matsuno.   

Abstract

CD36 deficiency was studied with attention to the phenotype-genotype relationship. The diagnosis of CD36 deficiency was made when CD36 was negative on platelets (type II) or on both platelets and monocytes (type I). Among 827 apparently healthy Japanese volunteers, the type I and II deficiencies were found in 8 (1.0%) and 48 (5.8%), respectively. The T for C substitution at nt478 for Pro90Ser and the insertion of A at nt 1159 constituted the major causes of type I and II deficiencies. The dinucleotide deletion at nt539 had a minor role. In two family studies, we found a previously unreported polymorphic site in the 5'-proximal flanking region and the 3'-untranslated region. Including these new polymorphisms, DNA sequence other than the three known mutations affecting CD36 expression was not observed in the CD36 gene, calling into question the previous hypothesis that a platelet-specific silent allele exists near or at the CD36 gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11019968

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

1.  Molecular basis of human CD36 gene mutations.

Authors:  Monika Ewa Rać; Krzysztof Safranow; Wojciech Poncyljusz
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 2.  Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.

Authors:  Tomoya Hayashi; Fumiya Hirayama
Journal:  Blood Transfus       Date:  2015-04-30       Impact factor: 3.443

3.  Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile.

Authors:  Latisha Love-Gregory; Richard Sherva; Timothy Schappe; Jian-Shen Qi; Jennifer McCrea; Samuel Klein; Margery A Connelly; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2010-10-08       Impact factor: 6.150

4.  CD36 deficiency and absent myocardial iodine-123-(R,S)-15-(p-iodophenyl)-3-methylpentadecanoic acid uptake in a girl with cardiomyopathy.

Authors:  Masayuki Teraguchi; Hiroyuki Ohkohchi; Yumiko Ikemoto; Hirohiko Higashino; Yohnosuke Kobayashi
Journal:  Eur J Pediatr       Date:  2003-02-12       Impact factor: 3.183

5.  Variants of CD36 gene and their association with CD36 protein expression in platelets.

Authors:  Xianguo Xu; Ying Liu; Xiaozhen Hong; Shu Chen; Kairong Ma; Xiaofei Lan; Yanling Ying; Ji He; Faming Zhu; Hangjun Lv
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

Review 6.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

7.  Attenuated aerobic exercise capacity in CD36 deficiency.

Authors:  Hidekatsu Yanai; Ichiro Watanabe; Kojiro Ishii; Mie Morimoto; Hironobu Fujiwara; Shigeru Yoshida; Shu-Ping Hui; Kazuhiko Matsuno; Hitoshi Chiba
Journal:  J Med Genet       Date:  2007-04-05       Impact factor: 6.318

Review 8.  Platelet adhesion under flow.

Authors:  Zaverio M Ruggeri
Journal:  Microcirculation       Date:  2009-01       Impact factor: 2.628

9.  Preliminary studies on CD36 gene in type 2 diabetic patients from north India.

Authors:  Sunaina Gautam; C G Agrawal; Hemant Kumar Bid; Monisha Banerjee
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

10.  Positive selection of a CD36 nonsense variant in sub-Saharan Africa, but no association with severe malaria phenotypes.

Authors:  Andrew E Fry; Anita Ghansa; Kerrin S Small; Alejandro Palma; Sarah Auburn; Mahamadou Diakite; Angela Green; Susana Campino; Yik Y Teo; Taane G Clark; Anna E Jeffreys; Jonathan Wilson; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Michael J Griffiths; Norbert Peshu; Thomas N Williams; Charles R Newton; Kevin Marsh; Malcolm E Molyneux; Terrie E Taylor; Kwadwo A Koram; Abraham R Oduro; William O Rogers; Kirk A Rockett; Pardis C Sabeti; Dominic P Kwiatkowski
Journal:  Hum Mol Genet       Date:  2009-04-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.